Nobel laureate and Caltech professor Robert Grubbs passed away on Sunday — a legendary chemist who was an ‘equally remarkable husband, father, grandfather, friend, and colleague,’ according to Dennis…
The FDA may soon sign off on two new pills from Merck and Pfizer to help treat Covid-19 before those infected end up in the hospital, according to a Bloomberg report. An announcement from the agency…
Alzheimer’s disease researchers along with medical professors from Harvard and Johns Hopkins issued a formal statement Monday asking the FDA to quickly pull Biogen’s Aduhelm from the market.
An injectable treatment for the prevention of HIV has been given the go-ahead by the FDA for use in adults and children weighing at least 77 pounds. Apretude is first given as two injections given a…
Psychedelic therapy has emerged once again as a potentially promising path to treating neurological conditions, but one tiny biotech is now facing a holdup at the FDA in bringing its LSD program to…
A young man with Duchenne muscular dystrophy has died in Pfizer’s Phase Ib trial of its mini-dystrophin gene therapy, triggering a halt in screening and dosing — and a clinical hold imposed by the…
Johnson & Johnson executive Michael Sneed is leading the pharma’s effort to talk about systemic racism in a new series that debuted this month. The six-episode series
Aldeyra Therapeutics’ shares tanked in premarket trading after the company admitted its dry eye candidate reproxalap missed the primary endpoint in a topline Phase III readout — but who needs the…
The director of the gastrointestinal oncology program at the University of Chicago Medical Center has been charged by the US attorney in Chicago with insider trading after he made more than $134,000…
Sanofi is crashing the year-end M&A party with a deal of its own. Immuno-oncology is the name of the game as it swallows Mountain View, CA-based Amunix for $1 billion upfront and up to $225 million in…
